Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients

Abstract Sialic acid-binding immunoglobulin-like lectin-15 (Siglec-15) is a new immune checkpoint molecule and its role of primary central nervous system lymphoma (PCNSL) tumor microenvironment has been unclear. We explored the Siglec-15 and programed death-ligand 1 (PD-L1) expression in tumor tissu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hirotaka Fudaba, Yasutomo Momii, Taisei Hirakawa, Kouhei Onishi, Daigo Asou, Wataru Matsushita, Yukari Kawasaki, Kenji Sugita, Minoru Fujiki
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d68bef7cadce40c1baa011d3079d925c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d68bef7cadce40c1baa011d3079d925c
record_format dspace
spelling oai:doaj.org-article:d68bef7cadce40c1baa011d3079d925c2021-12-02T14:01:23ZSialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients10.1038/s41598-020-79742-92045-2322https://doaj.org/article/d68bef7cadce40c1baa011d3079d925c2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79742-9https://doaj.org/toc/2045-2322Abstract Sialic acid-binding immunoglobulin-like lectin-15 (Siglec-15) is a new immune checkpoint molecule and its role of primary central nervous system lymphoma (PCNSL) tumor microenvironment has been unclear. We explored the Siglec-15 and programed death-ligand 1 (PD-L1) expression in tumor tissues and analyzed the association between the expression of these molecules and overall survival in newly diagnosed PCNSL. A total of 60 patients diagnosed with diffuse large B-cell lymphoma in PCNSL were included in this study. The Siglec-15 and PD-L1 expression on tumor cells, intratumoral macrophages and peritumoral macrophages were immunohistochemically evaluated. The expression of Siglec-15 and PD-L1 was greater in macrophages than in tumor cells. Regarding peritumoral macrophages, the number of Siglec-15-positive samples (n = 24) was greater than the number of PD-L1-positive samples (n = 16). A multivariate Cox analysis showed that the Siglec-15 positivity of peritumoral macrophages and performance of high-dose methotrexate-based chemotherapy were independent predictors of overall survival (hazard ratio: 0.295 and 0.322, respectively). The Kaplan–Meier survival curves showed that patients with Siglec-15-positive peritumoral macrophages had longer overall survival than those with Siglec-15-negative peritumoral macrophages (median overall survival: 3018 days and 746 days, respectively; p = 0.0290). Our findings indicate that the expression of Siglec-15 on peritumoral macrophages induces a favorable outcome in PCNSL patients.Hirotaka FudabaYasutomo MomiiTaisei HirakawaKouhei OnishiDaigo AsouWataru MatsushitaYukari KawasakiKenji SugitaMinoru FujikiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hirotaka Fudaba
Yasutomo Momii
Taisei Hirakawa
Kouhei Onishi
Daigo Asou
Wataru Matsushita
Yukari Kawasaki
Kenji Sugita
Minoru Fujiki
Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
description Abstract Sialic acid-binding immunoglobulin-like lectin-15 (Siglec-15) is a new immune checkpoint molecule and its role of primary central nervous system lymphoma (PCNSL) tumor microenvironment has been unclear. We explored the Siglec-15 and programed death-ligand 1 (PD-L1) expression in tumor tissues and analyzed the association between the expression of these molecules and overall survival in newly diagnosed PCNSL. A total of 60 patients diagnosed with diffuse large B-cell lymphoma in PCNSL were included in this study. The Siglec-15 and PD-L1 expression on tumor cells, intratumoral macrophages and peritumoral macrophages were immunohistochemically evaluated. The expression of Siglec-15 and PD-L1 was greater in macrophages than in tumor cells. Regarding peritumoral macrophages, the number of Siglec-15-positive samples (n = 24) was greater than the number of PD-L1-positive samples (n = 16). A multivariate Cox analysis showed that the Siglec-15 positivity of peritumoral macrophages and performance of high-dose methotrexate-based chemotherapy were independent predictors of overall survival (hazard ratio: 0.295 and 0.322, respectively). The Kaplan–Meier survival curves showed that patients with Siglec-15-positive peritumoral macrophages had longer overall survival than those with Siglec-15-negative peritumoral macrophages (median overall survival: 3018 days and 746 days, respectively; p = 0.0290). Our findings indicate that the expression of Siglec-15 on peritumoral macrophages induces a favorable outcome in PCNSL patients.
format article
author Hirotaka Fudaba
Yasutomo Momii
Taisei Hirakawa
Kouhei Onishi
Daigo Asou
Wataru Matsushita
Yukari Kawasaki
Kenji Sugita
Minoru Fujiki
author_facet Hirotaka Fudaba
Yasutomo Momii
Taisei Hirakawa
Kouhei Onishi
Daigo Asou
Wataru Matsushita
Yukari Kawasaki
Kenji Sugita
Minoru Fujiki
author_sort Hirotaka Fudaba
title Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
title_short Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
title_full Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
title_fullStr Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
title_full_unstemmed Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
title_sort sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d68bef7cadce40c1baa011d3079d925c
work_keys_str_mv AT hirotakafudaba sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT yasutomomomii sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT taiseihirakawa sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT kouheionishi sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT daigoasou sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT watarumatsushita sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT yukarikawasaki sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT kenjisugita sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
AT minorufujiki sialicacidbindingimmunoglobulinlikelectin15expressiononperitumoralmacrophagesisafavorableprognosticfactorforprimarycentralnervoussystemlymphomapatients
_version_ 1718392173235273728